1,438
Views
36
CrossRef citations to date
0
Altmetric
Editorial

Bioenergetics failure in neurodegenerative diseases: back to the future

, PhD
Pages 351-354 | Published online: 18 Feb 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (35)

Chaoguang Yang, Rui-Yuan Pan, Fangxia Guan & Zengqiang Yuan. (2024) Lactate metabolism in neurodegenerative diseases. Neural Regeneration Research 19:1, pages 69-74.
Crossref
Hangzhen Li, Fancai Zeng, Cancan Huang, Qiqi Pu, Elizabeth Rosalind Thomas, Yan Chen & Xiang Li. (2023) The potential role of glucose metabolism, lipid metabolism, and amino acid metabolism in the treatment of Parkinson's disease. CNS Neuroscience & Therapeutics.
Crossref
Marcello Serra, Anna Di Maio, Valentina Bassareo, Tommaso Nuzzo, Francesco Errico, Federica Servillo, Mario Capasso, Pathik Parekh, Qin Li, Marie-Laure Thiolat, Erwan Bezard, Paolo Calabresi, David Sulzer, Manolo Carta, Micaela Morelli & Alessandro Usiello. (2023) Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration. Neurobiology of Disease 184, pages 106226.
Crossref
Chengcheng Dai, Changhong Tan, Lili Zhao, Yi Liang, Guohui Liu, Hang Liu, Yuke Zhong, Zhihui Liu, Lijuan Mo, Xi Liu & Lifen Chen. (2023) Glucose metabolism impairment in Parkinson’s disease. Brain Research Bulletin 199, pages 110672.
Crossref
Wei Cao, Zhengzhe Feng, Deyuan Zhu, Suya Li, Meng Du, Shifei Ye, Dayong Qi, Peng Li, Yan Chen & Yibin Fang. (2023) The Role of PGK1 in Promoting Ischemia/Reperfusion Injury-Induced Microglial M1 Polarization and Inflammation by Regulating Glycolysis. NeuroMolecular Medicine 25:2, pages 301-311.
Crossref
Matthew A. Weber, Kartik Sivakumar, Ervina E. Tabakovic, Mayu Oya, Georgina M. Aldridge, Qiang Zhang, Jacob E. Simmering & Nandakumar S. Narayanan. (2023) Glycolysis-enhancing α1-adrenergic antagonists modify cognitive symptoms related to Parkinson’s disease. npj Parkinson's Disease 9:1.
Crossref
Hasan Turkez, Ozlem Altay, Serkan Yildirim, Xiangyu Li, Hong Yang, Cemil Bayram, Ismail Bolat, Sena Oner, Ozlem Ozdemir Tozlu, Mehmet Enes Arslan, Muhammad Arif, Burak Yulug, Lutfu Hanoglu, Seyda Cankaya, Simon Lam, Halil Aziz Velioglu, Ebru Coskun, Ezgi Idil, Rahim Nogaylar, Ahmet Ozsimsek, Ahmet Hacimuftuoglu, Saeed Shoaie, Cheng Zhang, Jens Nielsen, Jan Borén, Mathias Uhlén & Adil Mardinoglu. (2023) Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases. Life Sciences 314, pages 121325.
Crossref
L.Ya. Shtanova, S.P. Vesеlsky, P.I. Yanchuk, O.V. Tsymbalyuk, V.S. Moskvina, O.V. Shablykina, O.F. Moroz, T.V. Vovkun, О.V. Kravchenko & V.P. Khilya. (2022) Purine and lipid metabolism in rats with a rotenone model of Parkinson’s disease under the influence of methanindiazenone. Fiziolohichnyĭ zhurnal 68:6, pages 18-30.
Crossref
Jacob E. Simmering, Michael J. Welsh, Jordan Schultz & Nandakumar S. Narayanan. (2022) Use of Glycolysis‐Enhancing Drugs and Risk of Parkinson's Disease. Movement Disorders 37:11, pages 2210-2216.
Crossref
Li Gao, Min Cao, Guan-hua Du & Xue-mei Qin. (2022) Huangqin Decoction Exerts Beneficial Effects on Rotenone-Induced Rat Model of Parkinson's Disease by Improving Mitochondrial Dysfunction and Alleviating Metabolic Abnormality of Mitochondria. Frontiers in Aging Neuroscience 14.
Crossref
Julian Hofmann, Philipp Spatz, Rasmus Walther, Marcus Gutmann, Tangui Maurice & Michael Decker. (2022) Synthesis and Biological Evaluation of Flavonoid‐Cinnamic Acid Amide Hybrids with Distinct Activity against Neurodegeneration in Vitro and in Vivo. Chemistry – A European Journal 28:39.
Crossref
Roberto Federico Villa, Antonella Gorini & Federica Ferrari. (2022) Clonidine and Brain Mitochondrial Energy Metabolism: Pharmacodynamic Insights Beyond Receptorial Effects. Neurochemical Research 47:5, pages 1429-1441.
Crossref
Shao-Jia Qiang, Yu-Qi Shi, Tong-Yu Wu, Jing-Quan Wang, Xue-Lian Chen, Jie Su, Xin-Ping Chen, Jia-Zhong Li & Zhe-Sheng Chen. (2022) The Discovery of Novel PGK1 Activators as Apoptotic Inhibiting and Neuroprotective Agents. Frontiers in Pharmacology 13.
Crossref
Jingyi Li, Longmin Chen, Qixiong Qin, Danlei Wang, Jingwei Zhao, Hongling Gao, Xiao Yuan, Jing Zhang, Yuan Zou, Zhijuan Mao, Yongjie Xiong, Zhe Min, Manli Yan, Cong-yi Wang & Zheng Xue. (2022) Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson's disease. Neurobiology of Disease 163, pages 105605.
Crossref
Jordan L. Schultz, Alivia N. Brinker, Jia Xu, Sarah E. Ernst, Fariba Tayyari, Adam J. Rauckhorst, Lei Liu, Ergun Y. Uc, Eric B. Taylor, Jacob E. Simmering, Vincent A. Magnotta, Michael J. Welsh & Nandakumar S. Narayanan. (2022) A pilot to assess target engagement of terazosin in Parkinson's disease. Parkinsonism & Related Disorders 94, pages 79-83.
Crossref
Nandakumar S. Narayanan & Roger L. Albin. 2022. Cognition in Parkinson's Disease. Cognition in Parkinson's Disease 457 462 .
David Soriano-Castell, Zhibin Liang, Pamela Maher & Antonio Currais. (2021) Profiling the chemical nature of anti-oxytotic/ferroptotic compounds with phenotypic screening. Free Radical Biology and Medicine 177, pages 313-325.
Crossref
Yuzo Fujino, Takashi Kasai, Fukiko Kitani-Morii, Takuma Ohmichi, Makiko Shinomoto, Kanako Menjo & Toshiki Mizuno. (2021) Impaired age-dependent increases in phosphoglycerate kinase activity in red blood cells of Parkinson's disease patients. Parkinsonism & Related Disorders 91, pages 128-134.
Crossref
Flávia Malvestio Sisti, Neife Aparecida Guinaim dos Santos, Lilian do Amaral & Antonio Cardozo dos Santos. (2021) The Neurotrophic-Like Effect of Carvacrol: Perspective for Axonal and Synaptic Regeneration. Neurotoxicity Research 39:3, pages 886-896.
Crossref
Olayemi Joseph Olajide, Ismail Tayo Gbadamosi, Emmanuel Olusola Yawson, Tolulope Arogundade, Folashade Susan Lewu, Kehinde Yomi Ogunrinola, Oluwaseun Olaniyi Adigun, Olawande Bamisi, Ezra Lambe, Leviticus Ogbenevurinrin Arietarhire, Olushola Oladapo Oluyomi, Olumayowa Kolawole Idowu, Rukayat Kareem, Nnaemeka Tobechukwu Asogwa & Philip Adeyemi Adeniyi. (2021) Hippocampal Degeneration and Behavioral Impairment During Alzheimer-Like Pathogenesis Involves Glutamate Excitotoxicity. Journal of Molecular Neuroscience 71:6, pages 1205-1220.
Crossref
Jacob E. Simmering, Michael J. Welsh, Lei Liu, Nandakumar S. Narayanan & Anton Pottegård. (2021) Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease. JAMA Neurology 78:4, pages 407.
Crossref
Sandra Gunesch, David Soriano-Castell, Stephanie Lamer, Andreas Schlosser, Pamela Maher & Michael Decker. (2020) Development and Application of a Chemical Probe Based on a Neuroprotective Flavonoid Hybrid for Target Identification Using Activity-Based Protein Profiling. ACS Chemical Neuroscience 11:22, pages 3823-3837.
Crossref
Shaozhi Zhang, Sijie Wang, Xingzhu Shi & Xizeng Feng. (2020) Polydatin alleviates parkinsonism in MPTP-model mice by enhancing glycolysis in dopaminergic neurons. Neurochemistry International 139, pages 104815.
Crossref
Joséphine Zangari, Francesco Petrelli, Benoît Maillot & Jean-Claude Martinou. (2020) The Multifaceted Pyruvate Metabolism: Role of the Mitochondrial Pyruvate Carrier. Biomolecules 10:7, pages 1068.
Crossref
Sandra Gunesch, Matthias Hoffmann, Carolina Kiermeier, Wolfgang Fischer, Antonio F.M. Pinto, Tangui Maurice, Pamela Maher & Michael Decker. (2020) 7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo. Redox Biology 29, pages 101378.
Crossref
Rong Cai, Yu Zhang, Jacob E. Simmering, Jordan L. Schultz, Yuhong Li, Irene Fernandez-Carasa, Antonella Consiglio, Angel Raya, Philip M. Polgreen, Nandakumar S. Narayanan, Yanpeng Yuan, Zhiguo Chen, Wenting Su, Yanping Han, Chunyue Zhao, Lifang Gao, Xunming Ji, Michael J. Welsh & Lei Liu. (2019) Enhancing glycolysis attenuates Parkinson’s disease progression in models and clinical databases. Journal of Clinical Investigation 129:10, pages 4539-4549.
Crossref
Wolfgang Fischer, Antonio Currais, Zhibin Liang, Antonio Pinto & Pamela Maher. (2019) Old age-associated phenotypic screening for Alzheimer's disease drug candidates identifies sterubin as a potent neuroprotective compound from Yerba santa. Redox Biology 21, pages 101089.
Crossref
Olayemi Joseph Olajide, John Oluwasegun Fatoye, Oluwakunmi Folashade Idowu, Damilola Ilekoya, Ismail Temitayo Gbadamosi, Monsurat Titi Gbadamosi & Nnaemeka Tobechukwu Asogwa. (2018) Reversal of behavioral decline and neuropathology by a complex vitamin supplement involves modulation of key neurochemical stressors. Environmental Toxicology and Pharmacology 62, pages 120-131.
Crossref
Federica Ferrari, Antonella Gorini, Siegfried Hoyer & Roberto Federico Villa. (2018) Glutamate metabolism in cerebral mitochondria after ischemia and post-ischemic recovery during aging: relationships with brain energy metabolism. Journal of Neurochemistry 146:4, pages 416-428.
Crossref
Simon Schramm, Guozheng Huang, Sandra Gunesch, Florian Lang, Judit Roa, Petra Högger, Raimon Sabaté, Pamela Maher & Michael Decker. (2018) Regioselective synthesis of 7-O-esters of the flavonolignan silibinin and SARs lead to compounds with overadditive neuroprotective effects. European Journal of Medicinal Chemistry 146, pages 93-107.
Crossref
Pamela Maher & George J. Kontoghiorghes. (2015) Characterization of the Neuroprotective Potential of Derivatives of the Iron Chelating Drug Deferiprone. Neurochemical Research 40:3, pages 609-620.
Crossref
Antonio Currais, Chandramouli Chiruta, Marie Goujon-Svrzic, Gustavo Costa, Tânia Santos, Maria Teresa Batista, Jorge Paiva, Maria do Céu Madureira & Pamela Maher. (2014) Screening and identification of neuroprotective compounds relevant to Alzheimer׳s disease from medicinal plants of S. Tomé e Príncipe. Journal of Ethnopharmacology 155:1, pages 830-840.
Crossref
Roberto Federico Villa, Antonella Gorini, Federica Ferrari & Siegfried Hoyer. (2013) Energy metabolism of cerebral mitochondria during aging, ischemia and post-ischemic recovery assessed by functional proteomics of enzymes. Neurochemistry International 63:8, pages 765-781.
Crossref
R.F. Villa, F. Ferrari & A. Gorini. (2012) Energy metabolism of rat cerebral cortex, hypothalamus and hypophysis during ageing. Neuroscience 227, pages 55-66.
Crossref
Roberto Federico Villa, Federica Ferrari & Antonella Gorini. (2012) Effect of CDP-choline on age-dependent modifications of energy- and glutamate-linked enzyme activities in synaptic and non-synaptic mitochondria from rat cerebral cortex. Neurochemistry International 61:8, pages 1424-1432.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.